Veno‐occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation
2020 ◽
Vol 26
(1)
◽
pp. 197-203
◽
2018 ◽
Vol 97
(11)
◽
pp. 2173-2183
◽